Excessive sweating of the palms can be a persistent and socially limiting condition, particularly when symptoms interfere with professional work, interpersonal contact, writing, operating equipment, or routine daily activities. For selected patients with severe primary palmar hyperhidrosis, thoracic sympathectomy provides a surgical option by interrupting sympathetic nerve signals responsible for excessive palmar sweating.

This surgical video presents an advanced robotic bilateral T3 sympathectomy, demonstrating how robotic technology can be used for precise minimally invasive thoracic surgery. The procedure combines the principles of endoscopic sympathetic denervation with the visualization and instrument-control capabilities of robotic surgery.

The fundamental objective of the operation is straightforward: identify the appropriate sympathetic chain level and interrupt the neural pathway responsible for excessive sweating of the hands. However, achieving this objective safely requires detailed knowledge of thoracic anatomy, careful dissection and appropriate patient selection.

Robotic surgery can be particularly useful in confined anatomical spaces because the system may provide magnified three-dimensional visualization, articulated instruments and tremor reduction. These characteristics can help facilitate delicate dissection around the sympathetic chain. Published reviews of robotic sympathectomy describe potential advantages including improved dexterity and visualization, while also identifying limitations such as increased cost, system setup requirements and the need for specialized training.

During bilateral T3 sympathectomy, the surgeon approaches the sympathetic chain on each side of the thorax. The relevant thoracic level is identified using anatomical landmarks, and the intended sympathetic interruption is performed under direct visualization. The procedure requires meticulous attention to the surrounding structures because the sympathetic chain is located within a region containing important neural and vascular anatomy.

One of the major strengths of minimally invasive robotic surgery is the ability to perform delicate movements through small access ports. Instead of using a large thoracic incision, the operation can be performed through minimally invasive access, potentially reducing surgical trauma and facilitating postoperative recovery in appropriately selected patients.

However, the surgical objective should never be reduced simply to achieving a technically successful nerve interruption. Patient selection and preoperative counseling are fundamental. Primary palmar hyperhidrosis should be appropriately evaluated, and alternative nonsurgical treatment options should be considered before surgery. Patients should also understand that sympathetic denervation can produce changes in sweating elsewhere on the body.

The most important long-term consideration is compensatory hyperhidrosis, in which sweating increases in other areas after sympathetic denervation. The severity varies among patients, and the risk can be influenced by the extent and level of sympathetic interruption. Research comparing T3 and T4 approaches has demonstrated that the choice of level can affect postoperative sweating patterns, although no single level is appropriate for every patient.

Earlier randomized evidence has also supported the concept that limiting the extent of sympathetic denervation may reduce severe compensatory sweating without necessarily compromising palmar symptom control. In one randomized study, T3 treatment showed a lower incidence of severe compensatory sweating than T2–4 ablation.

The robotic platform may offer additional technical advantages during thoracic sympathetic surgery. A published case series of robotic selective postganglionic sympathectomy reported bilateral treatment and used robotic instruments for pleural dissection and division of sympathetic fibers. The study demonstrated the feasibility of robotic assistance while also highlighting the need to evaluate outcomes, complications and long-term symptom control.

This video can be particularly useful for surgeons studying robotic thoracic surgery and sympathetic nerve procedures. Important educational points include understanding the thoracic anatomy, establishing minimally invasive access, identifying the sympathetic chain, confirming the intended level, performing controlled dissection and maintaining awareness of structures that should be preserved.

The procedure also illustrates an important concept in modern robotic surgery: technology does not replace anatomical knowledge or surgical judgment. The robotic system provides the surgeon with enhanced visualization and instrument control, but the quality and safety of the operation remain dependent on appropriate planning, technical expertise, careful tissue handling and recognition of individual anatomical variations.

Published studies of thoracic sympathectomy have demonstrated substantial improvement in palmar sweating for appropriately selected patients, but they also consistently identify compensatory sweating as an important postoperative consideration.

For this reason, the phrase “easy minimally invasive solution” should be understood in the context of surgical accessibility rather than suggesting that the operation is universally simple or risk-free. Robotic T3 sympathectomy is a specialized procedure that requires appropriate training, thoracic surgical expertise, suitable equipment and careful patient evaluation.

As an educational surgical demonstration, this video showcases the evolution of treatment for palmar hyperhidrosis from conventional thoracic approaches toward increasingly precise minimally invasive and robotic techniques. It highlights how advanced visualization and robotic instrument control can be applied to a small but anatomically important target.

The video is intended for medical professionals, surgeons, robotic surgery trainees and healthcare learners who wish to understand the principles of robotic sympathectomy for palmar hyperhidrosis. Individual treatment decisions should always be made after appropriate clinical evaluation and discussion of potential benefits, alternatives and complications.